Analyst Price Targets — VNDA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 11, 2026 9:59 am | — | H.C. Wainwright | $21.00 | $6.28 | TheFly | Vanda Pharmaceuticals price target lowered to $21 from $24 at H.C. Wainwright |
| February 23, 2026 11:09 am | — | H.C. Wainwright | $24.00 | $8.48 | TheFly | Vanda Pharmaceuticals price target raised to $24 from $22 at H.C. Wainwright |
| January 5, 2026 11:05 am | — | H.C. Wainwright | $22.00 | $8.25 | TheFly | Vanda Pharmaceuticals price target raised to $22 from $20 at H.C. Wainwright |
| December 31, 2025 10:04 am | — | Jefferies | $7.50 | $7.03 | TheFly | Vanda Pharmaceuticals price target raised to $7.50 from $5 at Jefferies |
| November 5, 2025 7:42 am | Madison El-Saadi | B.Riley Financial | $11.00 | $4.35 | StreetInsider | B.Riley Starts Vanda Pharmaceuticals (VNDA) at Buy |
| July 11, 2024 6:12 am | Charles Duncan | Cantor Fitzgerald | $11.00 | $5.21 | TheFly | Vanda Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald |
Latest News for VNDA
WASHINGTON, Aug. 24, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that its investigational drug imsidolimab has received Orphan Designation from the European Commission, based on the positive opinion received from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP), for the treatment of Generalized Pustular Psoriasis (GPP), which is a severe,…
NEREUS⢠Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. PR Newswire WASHI
WASHINGTON, Aug. 22, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the NEREUS™ branded No. 47 entry from Rahal Letterman Lanigan Racing, driven by Mick Schumacher, is set to compete this weekend in the inaugural Freedom 250 Grand Prix of Washington, D.C.
PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.
Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VNDA.
U.S. House Trading
No House trades found for VNDA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.